BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Aptus Pharmaceuticals, Inc. is a drug discovery company that uses its proprietary technologies to develop therapeutics targeting G-Protein Coupled Receptors (GPCRs). More
The CEI is the technology transfer department of the University of Southampton. We are responsible for IP protection, licenses, spinouts and entrepreneurship throughout the University More